Jonathan Young
CIK 1779805 · Chief Operating Officer · last filed 2025-12-09
Jonathan Young is a Chief Operating Officer who has filed 61 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing, for AKRO, was dated Dec 9, 2025. Across all open-market trades the lifetime net is −$13.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
61
-$13.41M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) Delisted | Chief Operating Officer | 0 | $54.65 | $0 | -$13.41M | 61 | 2025-12-09 |
Recent Filings
61 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) Delisted | Disp (D) | −260,189 | $0 | EDGAR |
| 2025-11-26 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | +3,291 | $290.3K | EDGAR |
| 2025-10-03 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$333.2K | EDGAR |
| 2025-09-12 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −586 | -$25.2K | EDGAR |
| 2025-09-04 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$312.3K | EDGAR |
| 2025-08-13 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$333.6K | EDGAR |
| 2025-07-02 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | +890 | $21.2K | EDGAR |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −1,453 | -$79.7K | EDGAR |
| 2025-06-12 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −2,493 | -$134.6K | EDGAR |
| 2025-03-14 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −607 | -$27.2K | EDGAR |